. . . "NCT01835145" . "Randomized Phase II Study Comparing the MET Inhibitor Cabozantinib to Temozolomide/Dacarbazine in Ocular Melanoma"@en . . "Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery"@en . "2013-07-31T00:00:00Z"^^ . . . . . . . "Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery"@en . . "2016-10-21T00:00:00Z"^^ . . . . "clinical trial"@en . . . . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . "Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery"@en . "18"^^ . . . . . "47"^^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . . . . . "klinisch onderzoek"@nl . . .